A Breakthrough in Exercise Mimicry
Cellular Energy & Endurance Without the Treadmill
SLU-PP-332 is an innovative experimental compound engineered to simulate the profound metabolic adaptations traditionally triggered by sustained cardiovascular training.
Pioneering researchers at the University of Florida and collaborating academic institutions have demonstrated that this small molecule targets fundamental cellular pathways responsible for energy expenditure, fat burning, and muscle fiber transformation.
Pioneering researchers at the University of Florida and collaborating academic institutions have demonstrated that this small molecule targets fundamental cellular pathways responsible for energy expenditure, fat burning, and muscle fiber transformation.
Crucially, SLU-PP-332 operates without suppressing caloric intake or requiring additional physical output, opening new avenues for researching metabolic health and muscle preservation.
Key Compound Summary
-
Primary Target Estrogen-Related Receptor Alpha (ERRα) Agonist
-
Metabolic Mode Enhances resting fatty acid oxidation & energy expenditure
-
CNS Impact Non-stimulant mechanism (no elevated heart rate or jitters)
-
Research Status Clinical research phase
How SLU-PP-332 Works
Activates genetics to simulate intense endurance workouts.
ERRα Receptor Activation
SLU-PP-332 acts as a potent agonist (activator) for Estrogen-Related Receptors (ERRs), with a specific affinity for ERRα. These nuclear receptors regulate key metabolic gene networks in energy-demanding tissues such as skeletal muscle, liver, and heart.
Transcriptional Reprogramming
Upon activation, ERRα triggers gene transcription programs identical to those naturally activated during prolonged aerobic cardio. This stimulates mitochondrial biogenesis and shifts cellular energy production toward lipid utilization.
Key Potential Benefits
Clinical findings demonstrate widespread metabolic and physical enhancements.
Boosts Fat Metabolism
Encourages muscle and hepatic tissue to preferentially burn fatty acids for cellular energy rather than storing them in adipose tissue.
Aids Weight Loss
Reduces total fat mass and body weight in obese subjects without requiring reduced food consumption or forced physical exertion.
Improves Blood Sugar
Enhances peripheral insulin sensitivity and glucose clearance, supporting healthy metabolic homeostasis in insulin-resistant subjects.
Protects the Liver
Lowers lipid accumulation inside liver cells, offering protective effects against hepatic steatosis and fatty liver progression.
Increases Stamina
Significantly improves physical endurance capacity, enabling subjects to run longer distances and withstand sustained exertion.
Supports Muscle Health
Promotes fatigue-resistant oxidative muscle fibers (Type I) and helps counteract muscle wasting caused by age or inactivity.
Non-Stimulant Mechanism
Unlike conventional fat burners or metabolic agents, SLU-PP-332 operates exclusively via nuclear receptor gene transcription rather than central nervous system (CNS) stimulation. As a result, it does not induce tachycardia, elevated blood pressure, anxiety, or jitters.
Current Clinical Status
Important experimental context
All current clinical data and reported benefits stem from laboratory cellular assays and extensive model studies. Long-term human pharmacokinetics remain under investigation but continue to astound researchers.
Explore Peptopia Research Resources
Stay informed on emerging compounds, metabolic research, and cellular health breakthroughs.
Shop SLU-PP-332 Now